SOUTH SAN FRANCISCO, Calif., July 2 /PRNewswire-FirstCall/ -- Anesiva, ( Nachrichten ) Inc. today announced preliminary longer-term, follow-up results from a Phase 2 study showing that a 1mg treatment with Adlea(TM) (formerly 4975) in patients with moderate-to-severe osteoarthritis of the knee produced substantial reductions in pain that persisted for up to 12 weeks.
From: www.finanznachrichten.de
Monday, July 2, 2007
formerly 4975) in ...
Subscribe to:
Post Comments (Atom)
![Digitalpoint Geo Tracking [Enabled]](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_vT7fPU_WlPu_fEVZZRDaBEZ5VhWQKij8IXYPVuudmDs4-sHE7EL_Q_u5xwihzrlZJVuloO5kAk7m59-a6SGSCGNqC3-A=s0-d)
![PingOmatic AutoDiscovery [Enabled]](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_uG4e8Q9tqC5oBv0N86AU33HSsN5uDoXyFi3RtzMm2rg9s_s5L9NzLqyT1Kj6pUebuoucAHyzGoxKsqtFoGwsQcOOPXIYK5njmkI4cwDsCONvTvCFfkGnAObLdtYkSi=s0-d)
![Made with Palestinian Efforts [True]](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_uPTCbnGVfV2FZKEGvN_t2MM0kie6hZVos6buAcxve-4dgAQRw09lwlwzqmVrQTBbs9ac1piXmw2WSuQnO2jUo3_OBVzJ9x3UC5X-jCGdY4xtMefNCABBmRrg=s0-d)
No comments:
Post a Comment